Home/Pipeline/OneDraw A1C System

OneDraw A1C System

Diabetes Monitoring (HbA1c Testing)

ApprovedActive

Key Facts

Indication
Diabetes Monitoring (HbA1c Testing)
Phase
Approved
Status
Active
Company

About Drawbridge Health

Drawbridge Health is a private, pre-revenue diagnostics company pioneering a novel platform for simplified blood collection. Its flagship product, the OneDraw® Blood Collection System, is designed to enable patients or healthcare professionals to collect a small, high-quality blood sample easily at home or in point-of-care settings, which can then be mailed to a lab for analysis. This approach addresses key challenges in traditional venous blood draws, including patient discomfort, logistical barriers, and the need for trained phlebotomists. The company's strategy targets the growing demand for decentralized and digital health solutions, particularly in chronic disease management and clinical trials.

View full company profile

Other Diabetes Monitoring (HbA1c Testing) Drugs

DrugCompanyPhase
Premier Hb9210™ HbA1c AnalyzerTrinity BiotechApproved/Commercial